Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/2008

01-12-2008 | Research Paper

Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients

Authors: Zhi-jie Fu, Zhi-yong Ma, Qi-rong Wang, Da-peng Lei, Rong Wang, Chun-xi Liu, Xin-liang Pan

Published in: Clinical & Experimental Metastasis | Issue 8/2008

Login to get access

Abstract

Background CyclinD1 and p16 are involved in the regulation of G1 checkpoint and may play an important role in the tumorgenesis of laryngeal squamous cell carcinoma (LSCC). Previous studies have examined the level of expression of cyclinD1 or p16 in LSCC but no such information is available for their relation and their correlation with lymph node metastasis in Chinese patients. Patients and methods A total of 58 patients underwent surgical resection of laryngeal tumours in the Department of Otolaryngology, Qilu Hospital Shandong University between January 2001 and December 2002. All pathologic specimens were available for immunohistochemical study using antibodies against cyclinD1 and p16. Results Compared with normal epithelium, expression of CyclinD1 in the LSCC was significantly higher (62.1% vs. 10.0%, < 0.05), expression of p16 was significantly lower (48.3% vs. 90.0%, < 0.05); CyclinD1 expression in LSCC was up-regulated in TNM classification (r s = 0.409, < 0.05) as well as with cervical lymph node metastases (r s = 0.294, < 0.05); p16 expression in LSCC was down-regulated with cervical lymph node metastases (r s = −0.275, < 0.05); negative significant correlation between p16 immunostaining and CyclinD1 was observed in LSCC (r s = −0.331, < 0.05). Conclusion There was a negative correlation between CyclinD1 expression and p16 expression in LSCC. The over-expression of CyclinD1 and the under-expression of p16 may play a significant role in the incidence and development of LSCC and may be important indicators for cervical lymph node metastases in Chinese patients of LSCC.
Literature
1.
go back to reference Cattaruzza MS, Maisonneuve P, Boyle P (1996) Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 32B(5):293–305PubMedCrossRef Cattaruzza MS, Maisonneuve P, Boyle P (1996) Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 32B(5):293–305PubMedCrossRef
2.
go back to reference Li LD, Rao KQ, Zhang SW et al (2002) Statistical analysis of data from 12 cancer registries in China, 1993–1997. Bull Chin Cancer 11(9):497–507 (in Chinese) Li LD, Rao KQ, Zhang SW et al (2002) Statistical analysis of data from 12 cancer registries in China, 1993–1997. Bull Chin Cancer 11(9):497–507 (in Chinese)
3.
4.
go back to reference Greenlee RT, Hill-Harmon MB, Murray T et al (2001) Cancer statistics, 2001. CA Cancer J Clin 51(1):15–36PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T et al (2001) Cancer statistics, 2001. CA Cancer J Clin 51(1):15–36PubMedCrossRef
5.
go back to reference Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264(5157):436–440PubMedCrossRef Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264(5157):436–440PubMedCrossRef
6.
go back to reference Nadal A, Cardesa A (2003) Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 442(1):1–7PubMed Nadal A, Cardesa A (2003) Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 442(1):1–7PubMed
7.
go back to reference Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501–1512PubMedCrossRef Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501–1512PubMedCrossRef
8.
go back to reference Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366(6456):704–707PubMedCrossRef Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366(6456):704–707PubMedCrossRef
9.
10.
go back to reference Bartkova J, Lukas J, Strauss M et al (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10(4):775–778PubMed Bartkova J, Lukas J, Strauss M et al (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10(4):775–778PubMed
11.
go back to reference Lai S, El-Naggar AK (1999) Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lab Invest 79(3):255–260PubMed Lai S, El-Naggar AK (1999) Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lab Invest 79(3):255–260PubMed
12.
go back to reference Krecicki T, Smigiel R, Fraczek M et al (2004) Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J Laryngol Otol 118(9):676–680PubMedCrossRef Krecicki T, Smigiel R, Fraczek M et al (2004) Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J Laryngol Otol 118(9):676–680PubMedCrossRef
13.
go back to reference Dong Y, Sui L, Sugimoto K et al (2001) Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 95(4):209–215PubMedCrossRef Dong Y, Sui L, Sugimoto K et al (2001) Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 95(4):209–215PubMedCrossRef
14.
go back to reference Gallo O, Santucci M, Franchi A (1997) Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst 89(15):1161–1163PubMedCrossRef Gallo O, Santucci M, Franchi A (1997) Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst 89(15):1161–1163PubMedCrossRef
15.
go back to reference UICC (1997) TNM classification of malignant tumours, 5th edn. UICC, Geneva 1997 UICC (1997) TNM classification of malignant tumours, 5th edn. UICC, Geneva 1997
16.
go back to reference Lin HS, Berry GJ, Sun Z et al (2006) Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 4(62):1–7 Lin HS, Berry GJ, Sun Z et al (2006) Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 4(62):1–7
17.
go back to reference von Wasielewski R, Mengel M, Gignac S et al (2006) Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 45(11):1455–1459 von Wasielewski R, Mengel M, Gignac S et al (2006) Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 45(11):1455–1459
18.
go back to reference Medema RH, Herrera RE, Lam F et al (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92(14):6289–6293PubMedCrossRef Medema RH, Herrera RE, Lam F et al (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92(14):6289–6293PubMedCrossRef
19.
go back to reference Lukas J, Aagaard L, Strauss M et al (1995) Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1. Control Cancer Res 55(21):4818–4823 Lukas J, Aagaard L, Strauss M et al (1995) Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1. Control Cancer Res 55(21):4818–4823
20.
go back to reference Pignataro L, Pruneri G, Carboni N et al (1998) Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16(9):3069–3077PubMed Pignataro L, Pruneri G, Carboni N et al (1998) Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16(9):3069–3077PubMed
21.
go back to reference Capaccio P, Pruneri G, Carboni N et al (1997) Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 111(7):622–626PubMedCrossRef Capaccio P, Pruneri G, Carboni N et al (1997) Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 111(7):622–626PubMedCrossRef
22.
go back to reference Jares P, Fernandez PL, Campo E et al (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54(17):4813–4817PubMed Jares P, Fernandez PL, Campo E et al (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54(17):4813–4817PubMed
23.
go back to reference Takes RP, de Baatenburg Jong RJ, Schuuring E et al (1997) Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123(4):412–419PubMed Takes RP, de Baatenburg Jong RJ, Schuuring E et al (1997) Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123(4):412–419PubMed
24.
go back to reference El-Naggar AK, Lai S, Clayman GL et al (1999) Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 30(9):1013–1018PubMedCrossRef El-Naggar AK, Lai S, Clayman GL et al (1999) Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 30(9):1013–1018PubMedCrossRef
25.
go back to reference Takeuchi H, Ozawa S, Ando N et al (1997) Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3(12 Pt 1):2229–2236PubMed Takeuchi H, Ozawa S, Ando N et al (1997) Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3(12 Pt 1):2229–2236PubMed
26.
go back to reference Lukas J, Aagaard L, Strauss M et al (1995) Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 55(21):4818–4823PubMed Lukas J, Aagaard L, Strauss M et al (1995) Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 55(21):4818–4823PubMed
27.
go back to reference Namazie A, Alavi S, Olopade OI et al (2002) Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112(3):472–481PubMedCrossRef Namazie A, Alavi S, Olopade OI et al (2002) Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112(3):472–481PubMedCrossRef
Metadata
Title
Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients
Authors
Zhi-jie Fu
Zhi-yong Ma
Qi-rong Wang
Da-peng Lei
Rong Wang
Chun-xi Liu
Xin-liang Pan
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 8/2008
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-008-9207-x

Other articles of this Issue 8/2008

Clinical & Experimental Metastasis 8/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine